CAS No. |
545-46-0 |
|---|---|
中文名称 |
(3S,4aR,6aR,6bS,8aS,11R,12S,12aS,14aR,14bR)-8a-(羟甲基)-4,4,6a,6b,11,12,14b-七甲基-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-二十氢匹辛-3-醇 |
英文名称 |
(3S,4aR,6aR,6bS,8aS,11R,12S,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-ol |
别名 |
MFCD00009620 | NSC-159627 | (3beta)-Urs-12-ene-3,28-diol | AKOS016036269 | EINECS 266-293-4 | URS-12-ENE-3.BETA.,28-DIOL | 3,28-DIHYDROXYURS-12-ENE | SCHEMBL337913 | SR-05000002219 | UNII-W599R31ROT | Mal-heptanoic NHS ester | s9551 | SMP1_000309 | URS-12 |
标准英文名 |
(3S,4aR,6aR,6bS,8aS,11R,12S,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-ol |
MDL No. |
MFCD00009620 |
分子式 |
C30H50O2 |
分子量 |
442.73 |
精确分子量 |
442.38 |
SMILES |
C[C@H]1[C@H](C)CC[C@]2(CO)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12 |
标准SMILES |
CC1(C)[C@@H]2CC[C@]3(C)[C@H](CC=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@@]5(CC[C@@]34C)CO)[C@@]2(C)CC[C@@H]1O |
用途 |
Uvaol exhibits cardioprotective and antiarrhythmic effects; it shows significant antiarrhythmic activity against myocardial ischemia-reperfusion injury at a dose of 40 mg·kg⁻¹, comparable to propranolol; it possesses antibacterial properties and has been investigated in a pharmaceutical composition for the treatment of tonsillitis; it demonstrates both pro-inflammatory and anti-inflammatory activities. |
InChIKey |
XUARCIYIVXVTAE-ZAPOICBTSA-N |
|
|
评论 |
|---|